New sterile Phebra plant
February 7, 2014
Australian pharmaceutical
firm Phebra has announced that
manufacturing and product supply
from its new sterile manufacturing
plant at Lane Cove West has
commenced.
Phebra is a specialty
pharmaceutical company that
develops, manufactures and
markets medicines in Australia,
New Zealand, Asia, Canada and
parts of Europe.
The company’s products cover
a range of pharmaceuticals in
disease areas such as cystic fibrosis,
antidotes, diagnostics, oncology
and pain.
Phebra ceo Dr Mal Eutick, said
the company had relocated from
its previous site at Burns Bay
Road, Lane Cove, which has now
been closed and the site sold for
the development of a significant
number of residential units.
Eutick said the new plant, situated
at Orion Road, allowed Phebra
to greatly enhance its current
manufacturing capacity for the
local Australian and New Zealand
markets and wider export markets.
“The facility will deliver extra
production capacity for Phebra
to manufacture our wide range
of critical medicines, as well
as expanding our capability to
conduct all-important development
programs now and into the future,”
he added.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Feb 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Feb 14
